Vividion Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- April 30, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $82,000,000
Company Info
- Organizations Involved
- Celgene Corporation
- Company Description
- Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.
- Market
- Therapeutics for oncology and inflammation
- Location
- San Diego, California, USA
- Coinvestors
- Alexandria Venture Investments, Altitude Life Science Ventures, ARCH Venture Partners, BVF Partners, Cardinal Partners, Casdin Capital, Celgene Corporation, Mirae Asset Venture Investment, Mubadala Ventures, Nextech Invest, Trinitas Capital, Versant Ventures